Page last updated: 2024-08-24

3-iodobenzylguanidine and Alzheimer Disease

3-iodobenzylguanidine has been researched along with Alzheimer Disease in 33 studies

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's15 (45.45)29.6817
2010's14 (42.42)24.3611
2020's4 (12.12)2.80

Authors

AuthorsStudies
Blanc, F; Bousiges, O1
Durcan, R; Howe, K; Kane, JPM; Lawley, S; Lloyd, JJ; O'Brien, JT; Petrides, GS; Roberts, G; Thomas, AJ1
Komatsu, J; Nakajima, K; Okuda, K1
Ali, T; Allan, L; Barker, S; Barnett, N; Ciafone, J; Colloby, SJ; Donaghy, PC; Durcan, R; Firbank, MJ; Hamilton, CA; Howe, K; Lawley, S; Lloyd, J; O'Brien, J; Petrides, GS; Roberts, G; Taylor, JP; Thomas, AJ1
Boccardi, M; Herholz, K; Nobili, F; Picco, A; Ratib, O; Sonni, I; Varrone, A1
Abbasi, M; Afarideh, M; Aghamollaii, V; Ahmadi, M; Farzanefar, S; Ganji, M; Ghalandari, N; Loloee, S; Naseri, M; Tafakhori, A1
Arai, H; Arai, T; Asada, T; Fujishiro, H; Hanyu, H; Iizuka, O; Iseki, E; Kashihara, K; Komatsu, J; Kosaka, K; Maruno, H; Mizukami, K; Mizuno, Y; Mori, E; Nakajima, K; Nakamura, H; Nakano, S; Nakashima, K; Nishio, Y; Orimo, S; Samuraki, M; Takahashi, A; Taki, J; Tokuda, T; Urakami, K; Utsumi, K; Wada, K; Washimi, Y; Yamada, M; Yamasaki, J; Yamashina, S; Yoshita, M1
Inui, Y; Iwata, N; Manabe, Y; Sarai, M; Toyama, H1
De Deyn, PP; Engelborghs, S; Goeman, J; Hauth, L; Martin, JJ; Slaets, S; Van Acker, F; Versijpt, J1
Arai, H; Arai, T; Asada, T; Fujishiro, H; Hanyu, H; Iizuka, O; Iseki, E; Kashihara, K; Kosaka, K; Maruno, H; Mizukami, K; Mizuno, Y; Mori, E; Nakajima, K; Nakamura, H; Nakano, S; Nakashima, K; Nishio, Y; Orimo, S; Samuraki, M; Takahashi, A; Taki, J; Tokuda, T; Urakami, K; Utsumi, K; Wada, K; Washimi, Y; Yamada, M; Yamasaki, J; Yamashina, S; Yoshita, M1
Kim, JS; Lee, KS; Oh, YS; Park, HE; Park, JW; Song, IU; Yang, DW1
Fukasawa, R; Hanyu, H; Hatanaka, H; Hirao, K; Hirose, D; Kanetaka, H; Namioka, N; Sakurai, H; Shimizu, S; Umahara, T1
Antelmi, L; Biffi, AM; Calcagni, ML; Capitanio, S; Cecchin, D; Corso, A; Gabanelli, SV; Guerra, UP; Merello, M; Micheli, A; Muscio, C; Nobili, F; Piccardo, A; Pinto, P; Riva, R; Sacco, L; Stefanini, S; Tettamanti, M; Tiraboschi, P; Vai, P; Vidale, S; Volterrani, D1
Inui, Y; Kosaka, K; Manabe, Y; Toyama, H1
Fujii, K; Furukawa, Y; Kobayashi, S; Morii, H; Saito, T; Shirasaka, T; Tateno, M; Utsumi, K; Yasumura, S1
Matsuda, H; Mizumura, S; Waragai, M; Yamada, T1
Kinuya, S; Matsuo, S; Nakajima, K; Taki, J; Yoshita, M1
Aonuma, K; Asada, T; Homma, T; Kinoshita, T; Kosaka, K; Mizukami, K1
Endo, T; Hirokawa, K; Ichihara, K; Kitagawa, M; Kobayashi, T; Kurata, M; Takahashi, M; Toru, S; Uchihara, T1
Maeda, K; Sakai, K; Yamane, Y1
Kinuya, S; Matsuo, S; Nakajima, K; Okuda, K; Taki, J; Yamada, M; Yoshita, M1
Kasahata, N; Makita, Y; Nakamura, A; Orimo, S; Uchihara, T1
Ikeda, S; Momose, M; Nakamura, A; Oguchi, K; Ohara, S; Oide, T; Tokuda, T1
Kitagawa, Y1
Estorch, M1
Abe, K; Chikamori, T; Hanyu, H; Hirao, K; Iwamoto, T; Kanetaka, H; Koizumi, K; Shimizu, S; Usui, Y; Yamashina, A1
Matsumoto, Y; Nakajima, K; Noguchi-Shinohara, M; Taki, J; Yamada, M; Yokoyama, K; Yoshita, M1
Hanyu, H; Hirao, K; Iwamoto, T; Kanetaka, H; Sakurai, H; Shimizu, S1
Kitayama, M; Nakashima, K; Nakaso, K; Wada-Isoe, K1
Imamura, K; Kitamaya, M; Kowa, H; Nakashima, K; Wada-Isoe, K1
Azevedo, JC; Barbirato, GB; Boechat, Y; Cabral, H; Correa, PL; Dohmann, HF; Felix, RM; Manhães, AC; Mendes, MH; Mesquita, CT; Schmidt, GJ; Schmidt, SL; Tolentino, JC1
Aiba, I; Doyu, M; Hirayama, M; Ieda, T; Katayama, T; Sobue, G; Takeda, A; Watanabe, H1
Taki, J; Yamada, M; Yoshita, M1

Reviews

3 review(s) available for 3-iodobenzylguanidine and Alzheimer Disease

ArticleYear
Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer's Disease.
    International journal of molecular sciences, 2022, Jun-07, Volume: 23, Issue:12

    Topics: 3-Iodobenzylguanidine; Alzheimer Disease; Biomarkers; Diagnosis, Differential; Humans; Lewy Body Disease; Neurodegenerative Diseases; Tomography, Emission-Computed, Single-Photon

2022
Clinical validity of presynaptic dopaminergic imaging with 
    Neurobiology of aging, 2017, Volume: 52

    Topics: 3-Iodobenzylguanidine; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Nortropanes; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon

2017
Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2008, Volume: 52, Issue:4

    Topics: 3-Iodobenzylguanidine; Alzheimer Disease; Diagnosis, Differential; Humans; Lewy Body Disease; Parkinson Disease; Radionuclide Imaging; Sympathetic Nervous System

2008

Trials

1 trial(s) available for 3-iodobenzylguanidine and Alzheimer Disease

ArticleYear
Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.
    Neurology, 2006, Jun-27, Volume: 66, Issue:12

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Confounding Factors, Epidemiologic; Diagnosis, Differential; Female; Humans; Japan; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Prevalence; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity

2006

Other Studies

29 other study(ies) available for 3-iodobenzylguanidine and Alzheimer Disease

ArticleYear
Cardiac
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:4

    Topics: 3-Iodobenzylguanidine; Adult; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Case-Control Studies; Cohort Studies; Female; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Radiopharmaceuticals

2021
What does diagnostic threshold mean? Deterministic and probabilistic considerations.
    Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2021, Volume: 28, Issue:4

    Topics: 3-Iodobenzylguanidine; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Humans; Iodine Radioisotopes; Lewy Body Disease; Middle Aged; Probability; Radiopharmaceuticals; Sensitivity and Specificity

2021
Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
    Neurology, 2021, 06-08, Volume: 96, Issue:23

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Diagnosis, Differential; Female; Follow-Up Studies; Heart; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes

2021
Potential diagnostic value of
    Clinical neurology and neurosurgery, 2017, Volume: 163

    Topics: 3-Iodobenzylguanidine; Adolescent; Alzheimer Disease; Dementia; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; ROC Curve

2017
    Journal of neurology, neurosurgery, and psychiatry, 2018, Volume: 89, Issue:11

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Cross-Sectional Studies; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Sensitivity and Specificity

2018
Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Annals of nuclear medicine, 2014, Volume: 28, Issue:8

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Area Under Curve; Brain; Cohort Studies; Female; Humans; Iodine Radioisotopes; Lewy Bodies; Magnetic Resonance Imaging; Male; Models, Statistical; Models, Theoretical; Perfusion; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon

2014
Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis.
    International journal of geriatric psychiatry, 2015, Volume: 30, Issue:8

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Sensitivity and Specificity

2015
Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study.
    PloS one, 2015, Volume: 10, Issue:3

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Lewy Bodies; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Reproducibility of Results; ROC Curve; Sensitivity and Specificity

2015
(123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease.
    Journal of the neurological sciences, 2015, Oct-15, Volume: 357, Issue:1-2

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Female; Humans; Hypotension, Orthostatic; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Radionuclide Imaging; Radiopharmaceuticals

2015
Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:1

    Topics: 3-Iodobenzylguanidine; Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Lewy Body Disease; Male; Multimodal Imaging; Myocardial Perfusion Imaging; Tomography, Emission-Computed, Single-Photon

2016
(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative
    Annals of neurology, 2016, Volume: 80, Issue:3

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Corpus Striatum; Diagnosis, Differential; Female; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes

2016
123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies.
    Psychiatry research. Neuroimaging, 2017, Mar-30, Volume: 261

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Sensitivity and Specificity

2017
Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
    Dementia and geriatric cognitive disorders, 2008, Volume: 26, Issue:5

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Occipital Lobe; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2008
Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis.
    Dementia and geriatric cognitive disorders, 2008, Volume: 26, Issue:6

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cysteine; Dementia; Dementia, Vascular; Diagnosis, Differential; Disease Progression; Female; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2008
Decreased ventilatory response to hypercapnia in dementia with Lewy bodies.
    Annals of neurology, 2009, Volume: 65, Issue:5

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Female; Heart; Heart Rate; Humans; Hypercapnia; Hypotension, Orthostatic; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Neuropsychological Tests; Partial Pressure; Tidal Volume; Ventilation

2009
Depletion or preservation of cardiac sympathetic nerve - an autopsy-verified contrast in two cases of Alzheimer's disease with or without Lewy bodies.
    European neurology, 2010, Volume: 64, Issue:3

    Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Female; Hippocampus; Humans; Lewy Bodies; Lewy Body Disease; Male; Myocardium; Neurofilament Proteins; Radiopharmaceuticals; tau Proteins; Tyrosine 3-Monooxygenase

2010
Dementia with Lewy bodies is associated with higher scores on the Geriatric Depression Scale than is Alzheimer's disease.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2011, Volume: 11, Issue:3

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Comorbidity; Depressive Disorder; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Mental Status Schedule; Personality Inventory; Psychometrics; Radiopharmaceuticals; Retrospective Studies; Statistics as Topic; Tomography, Emission-Computed, Single-Photon

2011
Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:1

    Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Calibration; Databases, Factual; Diagnosis, Differential; Humans; Lewy Body Disease; Mediastinum; Myocardium; Phantoms, Imaging; Reference Standards; Retrospective Studies; Societies, Scientific; Tomography, Emission-Computed, Single-Photon

2012
Limbic and nigral Lewy bodies and Alzheimer's disease pathology mimicking progressive supranuclear palsy in a 75-year-old man with preserved cardiac uptake of MIBG.
    Journal of Alzheimer's disease : JAD, 2012, Volume: 32, Issue:4

    Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Diagnosis, Differential; Humans; Lewy Bodies; Limbic System; Magnetic Resonance Imaging; Male; Myocardium; Substantia Nigra; Supranuclear Palsy, Progressive

2012
Usefulness of [123I]metaiodobenzylguanidine ([123I]MIBG) myocardial scintigraphy in differentiating between Alzheimer's disease and dementia with Lewy bodies.
    Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:8

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Female; Heart; Humans; Lewy Bodies; Male; Middle Aged; Radiopharmaceuticals; tau Proteins; Tomography, Emission-Computed, Single-Photon

2003
Usefulness of [123I] MIBG myocardial scintigraphy for differential diagnosis of Alzheimer's disease and dementia with lewy bodies.
    Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:10

    Topics: 3-Iodobenzylguanidine; Alzheimer Disease; Diagnosis, Differential; Heart; Humans; Lewy Body Disease; Radionuclide Imaging; Radiopharmaceuticals

2003
From the heart to the brain via cardiac MIBG imaging.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:3

    Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Brain; Clinical Trials as Topic; Diagnosis, Differential; Heart; Humans; Lewy Body Disease; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

2006
Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:3

    Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Humans; Iofetamine; Lewy Body Disease; Perfusion; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

2006
Phenylephrine and pilocarpine eye drop test for dementia with Lewy bodies and Alzheimer's disease.
    Neuroscience letters, 2007, Mar-06, Volume: 414, Issue:2

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Iris; Lewy Body Disease; Male; Miosis; Miotics; Mydriasis; Mydriatics; Ophthalmic Solutions; Phenylephrine; Pilocarpine; Predictive Value of Tests; Pupil

2007
Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study.
    Journal of the neurological sciences, 2007, Sep-15, Volume: 260, Issue:1-2

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Humans; Lewy Body Disease; Middle Aged; Peptide Fragments; Phosphorylation; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; tau Proteins

2007
Serum heart-fatty acid binding protein levels in patients with Lewy body disease.
    Journal of the neurological sciences, 2008, Mar-15, Volume: 266, Issue:1-2

    Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Area Under Curve; Biomarkers; Diagnosis, Differential; Dopamine Agonists; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Parkinson Disease; Radiopharmaceuticals; ROC Curve; Tomography, Emission-Computed, Single-Photon

2008
Value of combining activated brain FDG-PET and cardiac MIBG for the differential diagnosis of dementia: differentiation of dementia with Lewy bodies and Alzheimer disease when the diagnoses based on clinical and neuroimaging criteria are difficult.
    Clinical nuclear medicine, 2008, Volume: 33, Issue:6

    Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart; Humans; Image Enhancement; Lewy Body Disease; Male; Radionuclide Imaging; Radiopharmaceuticals

2008
Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease.
    Journal of neurology, neurosurgery, and psychiatry, 2001, Volume: 70, Issue:6

    Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Female; Humans; Lewy Body Disease; Male; Middle Aged; Myocardium; Radionuclide Imaging; Radiopharmaceuticals

2001
A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies.
    Journal of neurology, neurosurgery, and psychiatry, 2001, Volume: 71, Issue:5

    Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Female; Heart; Humans; Hypotension, Orthostatic; Lewy Body Disease; Male; Middle Aged; Myocardium; Neuropsychological Tests; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Time Factors

2001